Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK
Tenormin 100 mg Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, round, biconvex, film-coated tablets of diameter 10 mm, which are intagliated with 100 on one face and bisected on the reverse face. The bisection is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Atenolol 100 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Atenolol |
Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects. |
| List of Excipients |
|---|
|
Gelatin |
Aluminium PVC blister strips of 14 tablets in cartons: 28 Tablets.
Aluminium PVC blister strips of 7 tablets: 504 Tablets (for Hospital Use) (pack is subdivided into 6 cartons each containing 12 blister strips i.e. 84 tablets).
AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK
PL 17901/0054
Date of first authorisation: 1st June 2000
Date of latest renewal: 5th November 2003
| Drug | Countries | |
|---|---|---|
| TENORMIN | Austria, Australia, Canada, Cyprus, Germany, Ecuador, Spain, Hong Kong, Italy, Japan, Malta, Mexico, Nigeria, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
